ACAZEN
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79275472
- Registration number
- 6253453
- Mark type
- Stylized text
- Filed
- 21 Nov 2019
- Published for opposition
- 10 Nov 2020
- Registered
- 26 Jan 2021
- Attorney of record
- Frank W. Compagni
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids
Owner
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 07 Jun 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 15 May 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 30 Apr 2021 — GENERIC MADRID TRANSACTION SENT TO IB
- 29 Apr 2021 — GENERIC MADRID TRANSACTION CREATED
- 26 Apr 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2020 — PUBLISHED FOR OPPOSITION
- 08 Nov 2020 — NOTIFICATION PROCESSED BY IB
- 21 Oct 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 21 Oct 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 21 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2020 — EXAMINER'S AMENDMENT ENTERED